 | • レポートコード：MRC2-11QY00177 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は化学療法誘発性悪心・嘔吐（CINV）治療薬のグローバル市場について調査・分析したレポートです。種類別（Aloxi、Zofran Generic、Kytril Generic、Emend、Akynzeo、SUSTOL、Rolapitant）市場規模、用途別（急性CINV、遅延CINV）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別化学療法誘発性悪心・嘔吐（CINV）治療薬の競争状況、市場シェア ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場：種類別市場規模 2015年-2020年（Aloxi、Zofran Generic、Kytril Generic、Emend、Akynzeo、SUSTOL、Rolapitant） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場：種類別市場規模予測 2021年-2026年（Aloxi、Zofran Generic、Kytril Generic、Emend、Akynzeo、SUSTOL、Rolapitant） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場：用途別市場規模 2015年-2020年（急性CINV、遅延CINV） ・世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場：用途別市場規模予測 2021年-2026年（急性CINV、遅延CINV） ・北米の化学療法誘発性悪心・嘔吐（CINV）治療薬市場分析：米国、カナダ ・ヨーロッパの化学療法誘発性悪心・嘔吐（CINV）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの化学療法誘発性悪心・嘔吐（CINV）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の化学療法誘発性悪心・嘔吐（CINV）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの化学療法誘発性悪心・嘔吐（CINV）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Helsinn、Heron Therapeutics、Merck、Tesaro ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market
The global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Scope and Market Size
Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market is segmented into
Aloxi
Zofran Generic
Kytril Generic
Emend
Akynzeo
SUSTOL
Rolapitant
Segment by Application, the Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market is segmented into
Acute CINV
Delayed CINV
Regional and Country-level Analysis
The Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share Analysis
Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chemotherapy Induced Nausea and Vomiting （CINV） Drugs business, the date to enter into the Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck
Tesaro
…
1 Study Coverage
1.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Introduction
1.2 Market Segments
1.3 Key Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Type
1.4.2 Aloxi
1.4.3 Zofran Generic
1.4.4 Kytril Generic
1.4.5 Emend
1.4.6 Akynzeo
1.4.7 SUSTOL
1.4.8 Rolapitant
1.5 Market by Application
1.5.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Application
1.5.2 Acute CINV
1.5.3 Delayed CINV
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2015-2026
2.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2015-2026
2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Competitor Landscape by Players
3.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers
3.1.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers
3.2.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue in 2019
3.2.5 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Price by Manufacturers
3.4 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Type (2015-2020)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Type (2015-2020)
4.1.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Application (2015-2020)
5.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020)
5.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Application (2015-2020)
5.1.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Price by Application (2015-2020)
5.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
6.1.1 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
6.1.2 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
6.3 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
7.3 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Region
8.1.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region
8.1.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
9.1.1 Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
9.1.2 Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
9.3 Central & South America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
10.1.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
10.1.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Description and Business Overview
11.2.3 Helsinn Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.2.5 Helsinn Related Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Corporation Information
11.3.2 Heron Therapeutics Description and Business Overview
11.3.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.3.5 Heron Therapeutics Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.4.5 Merck Related Developments
11.5 Tesaro
11.5.1 Tesaro Corporation Information
11.5.2 Tesaro Description and Business Overview
11.5.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.5.5 Tesaro Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Estimates and Projections by Region
12.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Segments
Table 2. Ranking of Global Top Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Aloxi
Table 5. Major Manufacturers of Zofran Generic
Table 6. Major Manufacturers of Kytril Generic
Table 7. Major Manufacturers of Emend
Table 8. Major Manufacturers of Akynzeo
Table 9. Major Manufacturers of SUSTOL
Table 10. Major Manufacturers of Rolapitant
Table 11. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Nausea and Vomiting （CINV） Drugs as of 2019)
Table 20. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Price (2015-2020) (USD/Pcs)
Table 23. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Type
Table 25. Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Type (2015-2020)
Table 29. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Share by Type (2015-2020)
Table 31. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 33. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Application (2015-2020)
Table 34. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 35. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 39. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 41. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Helsinn Corporation Information
Table 80. Helsinn Description and Major Businesses
Table 81. Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Helsinn Product
Table 83. Helsinn Recent Development
Table 84. Heron Therapeutics Corporation Information
Table 85. Heron Therapeutics Description and Major Businesses
Table 86. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Heron Therapeutics Product
Table 88. Heron Therapeutics Recent Development
Table 89. Merck Corporation Information
Table 90. Merck Description and Major Businesses
Table 91. Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Merck Product
Table 93. Merck Recent Development
Table 94. Tesaro Corporation Information
Table 95. Tesaro Description and Major Businesses
Table 96. Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Tesaro Product
Table 98. Tesaro Recent Development
Table 99. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 100. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. North America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. Europe: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 108. Asia Pacific: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Latin America: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Middle East and Africa: Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Players
Table 117. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Customers List
Table 118. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Picture
Figure 2. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aloxi Product Picture
Figure 4. Zofran Generic Product Picture
Figure 5. Kytril Generic Product Picture
Figure 6. Emend Product Picture
Figure 7. Akynzeo Product Picture
Figure 8. SUSTOL Product Picture
Figure 9. Rolapitant Product Picture
Figure 10. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Acute CINV
Figure 12. Delayed CINV
Figure 13. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Report Years Considered
Figure 14. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2015-2026 (K Pcs)
Figure 16. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region in 2019
Figure 19. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region in 2019
Figure 21. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue in 2019
Figure 23. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2019
Figure 26. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type in 2019
Figure 28. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2019
Figure 31. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application in 2019
Figure 33. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 36. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 42. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 43. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 46. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 58. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region in 2019
Figure 63. China Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 87. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 98. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Share by Application in 2019
Figure 111. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年） Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides…- CINV既存・パイプライン治療薬の世界市場（～2026年） Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV). Market Analysis and Insights: Global CINV Existing and Pipeline Drugs Market The global CINV Existing and Pipeline Drugs market size i…
- 術後悪心嘔吐（PONV）の世界市場（～2026年） The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe. Major factors boo…
- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年） Acral erythema, also called as hand-foot syndrome or palmar-plantar erythrodysesthesia, is characterized by swelling, redness, paraesthesia (numbness) and desquamation (skin peeling) of palms, soles and rarely on knees and elbow. Acryl erythema is an adverse drug reaction which typically appear afte…